Vascular Solutions Inc. (VASC) Reaches New 52-Week High at $47.84
Shares of Vascular Solutions Inc. (NASDAQ:VASC) hit a new 52-week high on Friday . The company traded as high as $47.84 and last traded at $47.74, with a volume of 49,266 shares traded. The stock had previously closed at $47.19.
Several analysts have recently commented on the stock. Zacks Investment Research cut shares of Vascular Solutions from a “buy” rating to a “hold” rating in a research note on Wednesday, June 29th. Piper Jaffray Cos. raised their target price on shares of Vascular Solutions from $45.00 to $49.00 and gave the stock an “overweight” rating in a research note on Tuesday, July 26th. Sidoti cut shares of Vascular Solutions from a “buy” rating to a “neutral” rating and set a $47.00 target price for the company. in a research note on Tuesday, July 12th. TheStreet upgraded shares of Vascular Solutions from a “hold” rating to a “buy” rating in a research note on Monday, July 25th. Finally, Canaccord Genuity restated a “buy” rating on shares of Vascular Solutions in a research note on Wednesday, August 10th. One investment analyst has rated the stock with a hold rating and four have assigned a buy rating to the stock. The company presently has an average rating of “Buy” and an average price target of $47.38.
The stock’s 50-day moving average price is $45.51 and its 200 day moving average price is $37.41. The company has a market capitalization of $835.02 million and a price-to-earnings ratio of 88.41.
Vascular Solutions (NASDAQ:VASC) last issued its quarterly earnings results on Monday, July 25th. The medical device company reported $0.33 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.30 by $0.03. The company earned $41.20 million during the quarter, compared to the consensus estimate of $41.40 million. The firm’s quarterly revenue was up 9.7% on a year-over-year basis. During the same quarter last year, the firm posted $0.29 EPS. Analysts forecast that Vascular Solutions Inc. will post $1.24 earnings per share for the current fiscal year.
In other Vascular Solutions news, VP William Rutstein sold 10,011 shares of the business’s stock in a transaction on Wednesday, July 27th. The shares were sold at an average price of $46.26, for a total transaction of $463,108.86. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CEO Howard Root sold 40,000 shares of the business’s stock in a transaction on Wednesday, July 27th. The shares were sold at an average price of $45.11, for a total transaction of $1,804,400.00. Following the sale, the chief executive officer now owns 347,840 shares of the company’s stock, valued at approximately $15,691,062.40. The disclosure for this sale can be found here.
An institutional investor recently raised its position in Vascular Solutions stock. Schwab Charles Investment Management Inc. raised its stake in shares of Vascular Solutions Inc. (NASDAQ:VASC) by 3.4% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 56,929 shares of the medical device company’s stock after buying an additional 1,892 shares during the period. Schwab Charles Investment Management Inc. owned about 0.33% of Vascular Solutions worth $1,958,000 as of its most recent SEC filing.
Vascular Solutions, Inc is a medical device company focused on bringing clinically advanced solutions to the market for treating coronary and peripheral vascular disease. The Company’s product line consists of devices and services that are sold to interventional cardiologists, interventional radiologists, electrophysiologists and vein practices around the world.
Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.